Breaking News Instant updates and real-time market news.

BOX

Box

$13.70

-0.13 (-0.94%)

, GIII

G-III Apparel

$21.43

1.2 (5.93%)

10:18
08/29/19
08/29
10:18
08/29/19
10:18

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Box (BOX) downgraded to Neutral from Outperform at First Analysis and to Hold from Buy at Craig-Hallum. 2. G-III Apparel (GIII) downgraded to Hold from Buy at Stifel with analyst Jim Duffy saying his more cautious outlook reflects "shocks" to his fiscal 2021 earnings estimates from tariffs on China manufactured goods sold in the U.S. 3. Tapestry (TPR) and Movado (MOV) downgraded to Market Perform from Outperform at Cowen. 4. Solid Biosciences (SLDB) downgraded to Sell from Neutral at Citi with analyst Joel Beatty saying the stock has nearly doubled over the last month without anything fundamental changing, which has opened up a sell opportunity. 5. Casey's General Stores (CASY) downgraded to Underperform from Sector Perform at RBC Capital with analyst Irene Nattel citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

BOX

Box

$13.70

-0.13 (-0.94%)

GIII

G-III Apparel

$21.43

1.2 (5.93%)

TPR

Tapestry

$20.32

-0.18 (-0.88%)

MOV

Movado

$20.01

-1.215 (-5.73%)

SLDB

Solid Biosciences

$8.05

-1.065 (-11.69%)

CASY

Casey's General Stores

$169.97

-0.63 (-0.37%)

  • 05

    Sep

  • 10

    Sep

  • 11

    Sep

  • 19

    Sep

  • 19

    Sep

  • 25

    Sep

  • 15

    Oct

  • 13

    Nov

BOX Box
$13.70

-0.13 (-0.94%)

06/04/19
06/04/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. U.S. Steel (X) downgraded to Sell from Neutral at Goldman Sachs with analyst Matthew Korn saying he expects the stock to weaken as the market continues to absorb the effects of materially lower steel prices. 2. Box (BOX) downgraded to Hold from Buy at Canaccord with Canaccord analyst Richard Davis saying the company's fundamental position is "too strong" for it to be executing this sporadically. 3. Kohl's (KSS) downgraded to Underweight from Neutral at Atlantic Equities. 4. MercadoLibre (MELI) downgraded to Neutral from Buy at BTIG with analyst Marvin Fong saying the stock's 94% advance year-to-date has fixed the "glaring price inefficiency" that its stock price had previously represented. 5. Ensign Group (ENSG) downgraded to Hold from Buy at SunTrust with analyst David MacDonald saying he is positive on the company's "local structure and unique M&A strategy," along with its solid growth and value-unlocking pending spin. However, MacDonald notes that the upcoming changes in Ensign Group's reimbursement structure carry some "uncertainty" and also sees the risk/reward on the stock as "balanced" at 21-times his expected FY20 earnings multiple. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/29/19
FANA
08/29/19
DOWNGRADE
Target $14
FANA
Neutral
Box downgraded to Neutral from Outperform at First Analysis
First Analysis analyst Terry Kiwala downgraded Box to Neutral from Outperform and lowered his price target for the shares to $14 from $22. The analyst hoped the company's Q2 results and guidance would provide evidence that its revenue growth could accelerate beyond the 10%-12% growth that guidance implies for the second half of 2019. However, he now has reduced confidence in this prospect. While the number of Box's over-$100,000 deals signed in Q2 was up 36% year-over-year, the number of over-$500,000 deals signed was down substantially year-over-year and over-$1M deals signed were flat, Kiwala tells investors in a research note. The analyst cites continued sales uncertainty for his downgrade to Neutral.
08/29/19
CHLM
08/29/19
DOWNGRADE
Target $15
CHLM
Hold
Box downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Chad Bennett downgraded Box to Hold from Buy and lowered his price target for the shares to $15 from $22. The company remains in a "no-man's land" for investors, and the time has come for "material changes" in leadership, Bennett tells investors in a research note following the company's Q2 results. The analyst says he's never come across a company that is a leader in a $40B total addressable market and "continues to mis-execute so badly." Box is "potentially an activist investor's dream," but five of the nine board members being founders or venture capitalizes presents a a "bit of a roadblock," says Bennett. He sees the stock as a "value trap" until material changes are taken.
08/29/19
DADA
08/29/19
NO CHANGE
Target $17
DADA
Buy
Box price target lowered to $17 from $19 at DA Davidson
DA Davidson analyst Rishi Jaluria lowered his price target on Box to $17, saying that while the company beat on Q2 earnings, the underlying metrics were less "rosy" with slowing growth in billings, decline in retention rates, below-consensus deferred revenues, and a slide in the number of $500K+ deals. The analyst still keeps his Buy rating on Box longer term, citing the company's "differentiated technology" and new products like Shield, Skills, and Relay, adding that at 2.8-times enterprise value to expected 2020 revenue, the stock offers "solid risk-reward".
GIII G-III Apparel
$21.43

1.2 (5.93%)

08/07/19
STFL
08/07/19
NO CHANGE
STFL
G-III, Yeti have higher than average risk from List 4 tariffs, says Stifel
Stifel analyst Jim Duffy said the direct, unmitigated impact of a proposed 10% tariff on "List 4" goods imported from China is contained to a single digit percentage headwind to calendar 2020 earnings for most of the 18 Sports and Lifestyle Brands companies he covers, though he identified G-III Apparel (GIII), Yeti (YETI) and potentially Dick's Sporting Goods (DKS) as having higher than group average exposure to the risk. He awaits more tariff details before adjusting estimates, but said he is constructive on higher-end and globally diversified brands, such as Lululemon (LULU), Columbia Sportswear (COLM), Nike (NKE), Under Armour (UAA) and VF Corp. (VFC).
08/29/19
STFL
08/29/19
DOWNGRADE
Target $20
STFL
Hold
G-III Apparel downgraded to Hold from Buy at Stifel
Stifel analyst Jim Duffy downgraded G-III Apparel to Hold from Buy and lowered his price target for the shares to $20 from $37. The analyst says his more cautious outlook reflects "shocks" to his fiscal 2021 earnings estimates from tariffs on China manufactured goods sold in the U.S. G-III has the greatest earnings exposure to incremental tariffs among the Sports & Lifestyle Brands group, Duffy tells investors in a research note. The analyst believes a catalyst for a "sentiment reversion is unlikely through year-end."
08/02/19
PIPR
08/02/19
NO CHANGE
PIPR
More tariffs could bring 'near-term pain' for retail margins, says Piper Jaffray
Piper Jaffray analyst Erinn Murphy revisited her views on the Global Lifestyle Brands group after President Trump announced a 10% tariff on all remaining goods coming from China starting September. In her group, Steven Madden (SHOO) and G-III Apparel (GIII) have the most direct incremental exposure to China. Her biggest concern, however, is that the tariffs come right into the back-to-school and holiday season. Goods have been priced and contracts for future orders have been inked, which presents "near-term pain" for gross margins as re-ticketing goods intra-season "can be tricky," Murphy tells investors in a research note. Retail stocks reacted aggressively on yesterday afternoon following Trump's tweet, which creates some opportunities, says Murphy. The analyst would be buyers of Under Armour (UAA), Nike (NKE) and VF Corp. (VFC). These names have diversified global footprints and lower than average exposure in China, she contends. On the flip side, if the Chinese consumer travels less, Ralph Lauren (RL), PVH Corp. (PVH), Tapestry (TPR), Capri Holdings (CPRI) and G-III could be hurt, cautions Murphy.
06/05/19
STFL
06/05/19
NO CHANGE
STFL
G-III Apparel overcorrection an 'attractive entry point,' says Stifel
Stifel analyst Jim Duffy maintained a Buy rating and $37 price target on G-III Apparel, saying that while "skepticism will likely prevail near-term" in light of potential tariff risks, the analyst believes G-III's stock has overcorrected, creating an "attractive entry point."
TPR Tapestry
$20.32

-0.18 (-0.88%)

08/29/19
COWN
08/29/19
DOWNGRADE
COWN
Market Perform
Tapestry downgraded to Market Perform from Outperform at Cowen
Cowen analyst Oliver Chen downgraded Tapestry to Market Perform from Outperform.
08/29/19
COWN
08/29/19
DOWNGRADE
COWN
Market Perform
Tapestry downgraded to Market Perform at Cowen
As reported previously, Cowen analyst Oliver Chen downgraded Tapestry to Market Perform from Outperform. The analyst cited the lack of upside at Kate Spade, product changes necessary at Kate, and the time and risk on related improved customer reception. He also said he is cautious on Kate Spade and Coaches' exposure to promotional North American outlet malls. Chen maintained his $22 price target on Tapestry shares.
08/16/19
08/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. BHP Group (BHP) downgraded to Underperform from Neutral at BofA/Merrill with analyst Jason Fairclough saying the Chinese economy is likely to get worse before getting better. 2. Hexcel (HXL) downgraded to Sell from Neutral at Goldman Sachs with analyst Noah Poponak saying after re-rating year-to-date, the shares are the high-end of the historical valuation range. 3. Tapestry (TPR) downgraded to Perform from Outperform at Oppenheimer, to Neutral from Buy at MKM Partners, to Neutral from Conviction Buy at Goldman Sachs, to Neutral from Overweight at Piper Jaffray, and to Neutral from Outperform at Credit Suisse. 4. Whiting Petroleum (WLL) downgraded to Market Perform from Outperform at Wells Fargo with analyst Gordon Douthat saying the company's free cash generation potential is highly sensitive to oil price levels. 5. Best Inc (BEST) downgraded to Sector Weight from Overweight at KeyBanc with analyst Hans Chung citing the company's Q2 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/20/19
BOFA
08/20/19
NO CHANGE
BOFA
BofA/Merrill US 1 List changes
BofA/Merrill added Raytheon (RTN) to the US 1 List and removed AT&T (T), Williams (WMB), General Dynamics (GD) and Tapestry (TPR).
MOV Movado
$20.01

-1.215 (-5.73%)

10/08/18
10/08/18
UPGRADE
Target $50

Outperform
Movado upgraded to Outperform after managment meetings at Cowen
As previously reported, Cowen analyst Oliver Chen upgraded Movado to Outperform from Market Perform following meetings with CFO Sallie DeMarsilis that made him more constructive on the stock. His upgrade is mainly based on expectations of positive inflection in the U.S. Wholesale channel, but Chen said he also likes the company's strong fundamentals and "impressive" International Wholesale channel growth. The analyst, who views the recent pullback as a compelling entry point, has a $50 price target on Movado shares.
08/29/19
COWN
08/29/19
DOWNGRADE
COWN
Market Perform
Movado downgraded to Market Perform from Outperform at Cowen
Cowen analyst Oliver Chen downgraded Movado to Market Perform from Outperform.
08/29/19
COWN
08/29/19
DOWNGRADE
Target $22
COWN
Market Perform
Movado downgraded to Market Perform at Cowen
As reported previously, Cowen analyst Oliver Chen downgraded Movado to Market Perform from Outperform. The analyst moved tot he sidelines given lower visibility into future growth, and a deceleration of revenue growth combined with expense de-leverage. He said key headwinds include, category pressures, US and International Wholesale challenges, consumer confidence risk, and tariffs. Chen lowered his price target to $22 from $40 on Movado shares.
11/29/18
IBBA
11/29/18
UPGRADE
IBBA
Outperform
America Movil upgraded to Outperform from Market Perform at Itau BBA
SLDB Solid Biosciences
$8.05

-1.065 (-11.69%)

08/19/19
LEER
08/19/19
UPGRADE
LEER
Outperform
Solid Biosciences upgraded to Outperform from Market Perform at SVB Leerink
08/29/19
SBSH
08/29/19
DOWNGRADE
Target $6
SBSH
Sell
Solid Biosciences downgraded to Sell from Neutral at Citi
Citi analyst Joel Beatty downgraded Solid Biosciences to Sell from Neutral with a $6 price target.
08/29/19
SBSH
08/29/19
DOWNGRADE
Target $6
SBSH
Sell
Citi downgrades Solid Biosciences to Sell after doubling of shares in past month
Citi analyst Joel Beatty downgraded Solid Biosciences to Sell from Neutral with an unchanged price target of $6. The stock has nearly doubled over the last month without anything fundamental changing, which has opened up a sell opportunity, Beatty tells investors in a research note. The analyst continues to believe that SGT-001 is unlikely to reach approval in the U.S. in its current form "because the dystrophin expression data is unlikely to be competitive, even with the recent increase in dose."
08/19/19
LEER
08/19/19
UPGRADE
Target $15
LEER
Outperform
Solid Biosciences upgraded to Outperform with $15 target at SVB Leerink
As previously reported, SVB Leerink analyst Joseph Schwartz upgraded Solid Biosciences (SLDB) to Outperform from Market Perform after reassessing the protocol amendments and enrollment progress communicated by the company for its Phase 1/2 IGNITE-DMD trial. He believes much of the concerns that have weighed on the stock are baked-in at this point and continues to believe that Solid's scalable manufacturing "could be an underappreciated X-factor" that could potentially help it catch-up to the leader in the DMD space, Sarepta (SRPT). Schwartz raised his price target on Solid shares to $15 from $8.
CASY Casey's General Stores
$169.97

-0.63 (-0.37%)

08/07/19
08/07/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Aramark (ARMK) downgraded to Neutral from Outperform at Baird and to Hold from Buy at Stifel. 2. Casey's General Stores (CASY) downgraded to Hold from Buy at Gabelli. 3. Quotient Technology (QUOT) downgraded to Underperform from Neutral at BofA/Merrill, to Neutral from Buy at Dougherty, and to Outperform from Strong Buy at First Analysis. 4. Patterson-UTI (PTEN) downgraded to Sector Perform from Outperform at Scotiabank. 5. SiteOne Landscape (SITE) downgraded to Hold from Buy at Berenberg with analyst Alex Maroccia saying he believes weather has hampered the company's ability to deliver the top end of its full-year adjusted EBITDA target of $207M. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/29/19
RBCM
08/29/19
DOWNGRADE
Target $158
RBCM
Underperform
Casey's General Stores cut to Underperform from Sector Perform at RBC Capital
RBC Capital analyst Irene Nattel downgraded Casey's General Stores to Underperform on valuation, saying the the market appears to have discounted the company's potential to reach the high end of its FY20/21 guidance. The analyst notes that Casey's is faced with the continued challenges in farm economy along with competition from the incumbent and alternative channels. Nattel boosts her price target on the shares to $158 from $144 and also increases her Q1 EPS view to $2.47 from $2.11, adjusting her implied target multiple for expected forward EBITDA to 10.5-times from 9.75-times to reflect the strong fuel margin environment.
08/29/19
RBCM
08/29/19
DOWNGRADE
Target $158
RBCM
Underperform
Casey's General downgraded to Underperform from Sector Perform at RBC Capital
RBC Capital analyst Irene Nattel downgraded Casey's General Stores to Underperform from Sector Perform while raising her price target for the shares to $158 from $144.
08/06/19
GABE
08/06/19
DOWNGRADE
GABE
Hold
Casey's General Stores downgraded to Hold from Buy at Gabelli
Gabelli analyst Damian Witkowski downgraded Casey's General Stores to Hold.

TODAY'S FREE FLY STORIES

DB

Deutsche Bank

$8.43

-0.115 (-1.35%)

14:32
01/17/20
01/17
14:32
01/17/20
14:32
Periodicals
Deutsche Bank slashes investment bank bonuses by roughly 30%, Bloomberg says »

Deutsche Bank is lowering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

14:30
01/17/20
01/17
14:30
01/17/20
14:30
Options
MIAX SPIKES options volume over 100K contracts is new record »

MIAX SPIKES options…

INSG

Inseego

$9.23

0.76 (8.97%)

14:25
01/17/20
01/17
14:25
01/17/20
14:25
Options
Inseego call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSTG

NanoString

$30.44

-0.41 (-1.33%)

14:23
01/17/20
01/17
14:23
01/17/20
14:23
Hot Stocks
Pura Vida reports 5.37% passive stake in NanoString »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
01/17/20
01/17
14:17
01/17/20
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
01/17/20
01/17
14:16
01/17/20
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENV

Envestnet

$70.39

-4.05 (-5.44%)

14:06
01/17/20
01/17
14:06
01/17/20
14:06
Hot Stocks
Lawmakers urge FTC to investigate Envestnet over sale of financial data »

Several U.S. lawmakers,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

SNCA

Seneca Biopharma

$3.80

2.55 (204.00%)

14:06
01/17/20
01/17
14:06
01/17/20
14:06
Syndicate
Seneca Biopharma announces exercise of warrants for $7.55M gross proceeds »

Seneca Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHT

DHT Holdings

$7.41

0.19 (2.63%)

14:05
01/17/20
01/17
14:05
01/17/20
14:05
Options
DHT Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
01/17/20
01/17
14:05
01/17/20
14:05
General news
Action Economics Survey results: »

Action Economics Survey…

BGNE

BeiGene

$169.60

1.72 (1.02%)

14:03
01/17/20
01/17
14:03
01/17/20
14:03
Upgrade
BeiGene rating change  »

BeiGene upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

SNE

Sony

$72.46

-0.09 (-0.12%)

, CMCSA

Comcast

$47.43

0.57 (1.22%)

13:57
01/17/20
01/17
13:57
01/17/20
13:57
On The Fly
Box Office Battle: 'Bad Boys for Life' opens strong »

Welcome to "Box Office…

SNE

Sony

$72.46

-0.09 (-0.12%)

CMCSA

Comcast

$47.43

0.57 (1.22%)

CMCSK

Comcast

$0.00

(0.00%)

T

AT&T

$38.33

0.3 (0.79%)

DIS

Disney

$144.67

-0.43 (-0.30%)

LGF.A

Lionsgate

$10.94

-0.34 (-3.01%)

LGF.B

Lionsgate

$10.30

-0.325 (-3.06%)

VIAC

ViacomCBS

$39.64

-0.41 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

  • 04

    Feb

  • 04

    Feb

  • 06

    Feb

  • 06

    Feb

BA

Boeing

$325.18

-6.82 (-2.05%)

13:46
01/17/20
01/17
13:46
01/17/20
13:46
Periodicals
Boeing tells CNBC 'making necessary updates' to MAX after report of new issue »

After ABC's David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BA

Boeing

$326.24

-5.76 (-1.73%)

13:43
01/17/20
01/17
13:43
01/17/20
13:43
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing down 2% to $325.88…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

VB

Vanguard Small-Cap Index Fund

$169.72

-0.13 (-0.08%)

, IVV

iShares Core S&P 500

$333.10

0.72 (0.22%)

13:43
01/17/20
01/17
13:43
01/17/20
13:43
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week creations…

VB

Vanguard Small-Cap Index Fund

$169.72

-0.13 (-0.08%)

IVV

iShares Core S&P 500

$333.10

0.72 (0.22%)

TLT

iShares 20+ Year Treasury Bond Fund

$138.05

-1.15 (-0.83%)

ESGU

iShares ESG MSCI U.S.A. ETF

$73.74

0.27 (0.37%)

VCSH

Vanguard Short-Term Corporate Bond Index Fund

$81.21

0.025 (0.03%)

SPY

SPDR S&P 500 ETF Trust

$331.63

0.73 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$326.27

-5.73 (-1.73%)

13:42
01/17/20
01/17
13:42
01/17/20
13:42
Periodicals
ABC learns of another software issue with Boeing 737 Max »

ABC's David Kerley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

JNJ

Johnson & Johnson

$148.97

0.72 (0.49%)

13:39
01/17/20
01/17
13:39
01/17/20
13:39
Periodicals
Judge slashes J&J verdict down to $6.8M from $8B in Risperdal suit, Law.com says »

Philadelphia Court of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Mar

  • 17

    Mar

JNJ

Johnson & Johnson

$149.03

0.78 (0.53%)

13:17
01/17/20
01/17
13:17
01/17/20
13:17
Periodicals
Judge cuts J&J punishment in Risperdal case to $6.8M from $8B, Bloomberg reports »

On October 8, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Mar

  • 17

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
01/17/20
01/17
13:17
01/17/20
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
01/17/20
01/17
13:16
01/17/20
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKR

Baker Hughes

$23.56

0.06 (0.26%)

13:04
01/17/20
01/17
13:04
01/17/20
13:04
Hot Stocks
Baker Hughes reports U.S. rig count up 15 to 796 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Mar

MDR

McDermott

$0.73

0.0119 (1.66%)

13:02
01/17/20
01/17
13:02
01/17/20
13:02
Hot Stocks
McDermott announces start of commercial operation of Freeport LNG Train 2 »

McDermott International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$240.69

0.17 (0.07%)

13:02
01/17/20
01/17
13:02
01/17/20
13:02
Recommendations
Amgen analyst commentary  »

Amgen raised prices today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

BKR

Baker Hughes

$23.57

0.07 (0.30%)

13:01
01/17/20
01/17
13:01
01/17/20
13:01
Hot Stocks
Breaking Hot Stocks news story on Baker Hughes »

Baker Hughes reports U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Mar

SNCA

Seneca Biopharma

$3.09

1.84 (147.20%)

12:59
01/17/20
01/17
12:59
01/17/20
12:59
Hot Stocks
Seneca Biopharma surges after saying talks starting with 'interested parties' »

Shares of micro-cap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.